Search results

Jump to navigation Jump to search

Page title matches

Page text matches

  • #Redirect [[Vaccine]]
    21 bytes (2 words) - 17:12, 24 October 2008
  • #REDIRECT [[Pneumococcal vaccine]]
    34 bytes (3 words) - 14:25, 12 July 2010
  • #REDIRECT [[Pneumococcal vaccine]]
    34 bytes (3 words) - 21:14, 10 March 2015
  • ...and vaccination - Detailed explaination of the vaccine and history of the vaccine. : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1200696/?tool=pmcentrez
    757 bytes (111 words) - 13:31, 11 December 2009
  • [[Vaccine]]s or candidate vaccines used to prevent infections with [[streptococcus pn
    166 bytes (18 words) - 17:47, 14 May 2010
  • Auto-populated based on [[Special:WhatLinksHere/Pneumococcal vaccine]]. Needs checking by a human. {{r|Vaccine}}
    573 bytes (73 words) - 19:36, 11 January 2010
  • ..., [[voltage]]) or microorganism (e.g., an attenuated [[virus]] used in a [[vaccine]]
    174 bytes (25 words) - 10:36, 18 October 2008
  • ...liomyelitis (commonly known as polio) prior to the development of the Salk vaccine.
    247 bytes (31 words) - 06:40, 15 September 2020
  • ...ion against Clonorchis sinensis". ''Vaccine'' [http://dx.doi.org/10.1016/j.vaccine.2008.02.015 26:1817-25]
    1 KB (151 words) - 03:01, 16 February 2010
  • ...ia]], transplanted tissue, [[cancer]], and [[protozoa]]. The success of [[vaccine|vaccines]] is based on their antigenic properties.
    302 bytes (38 words) - 00:22, 31 December 2007
  • Johnson IS. Coordinating vaccine use is best way to combat polio.[comment]. [Comment. Letter] Nature. 435(70 ...Recommendations for the US poliovirus vaccine stockpile from the National Vaccine Advisory Committee (NVAC) and the Advisory Committee on Immunization Practi
    2 KB (257 words) - 10:03, 2 December 2013
  • {{r|Pneumococcal vaccine}}
    348 bytes (42 words) - 23:54, 26 January 2011
  • {{r|Vaccine}}
    329 bytes (39 words) - 19:28, 18 December 2008
  • ...pps.edu] - 'Scripps Research Scientists Successfully Test New Anti-Obesity Vaccine'
    985 bytes (127 words) - 08:19, 8 November 2010
  • ...dual to be protected. The immune system of that individual responds to the vaccine and, if that response is adequate, exposure to the germ will not result in ...[http://www.cdc.gov/vaccines/pubs/pinkbook/ Epidemiology and Prevention of Vaccine-Preventable Diseases]. Atkinson W, Wolfe S, Hamborsky J, McIntyre L, eds. 1
    4 KB (593 words) - 14:32, 2 February 2023
  • {{r|Nazi typhus and other vaccine experiments}}
    509 bytes (57 words) - 10:13, 30 January 2011
  • {{r|Pneumococcal vaccine}}
    506 bytes (62 words) - 11:13, 11 January 2010
  • {{r|Vaccine}}
    476 bytes (61 words) - 19:23, 11 January 2010
  • {{r|Pneumococcal vaccine}}
    575 bytes (73 words) - 10:33, 23 March 2024
  • {{r|Pneumococcal vaccine}}
    615 bytes (74 words) - 11:13, 11 January 2010
  • {{r|Vaccine}}
    511 bytes (65 words) - 07:43, 8 January 2010
  • {{r|Vaccine}}
    640 bytes (83 words) - 18:38, 11 January 2010
  • {{r|Pneumococcal vaccine}}
    590 bytes (74 words) - 17:26, 11 January 2010
  • {{r|Pneumococcal vaccine}}
    743 bytes (95 words) - 20:39, 11 January 2010
  • {{r|Vaccine}}
    798 bytes (102 words) - 21:26, 11 January 2010
  • ...can]]|language=en |quote=For more than a decade, Kennedy has promoted anti-vaccine propaganda completely unconnected to reality.}}</ref> ..., 2021 |publisher=NBC News |quote=The video the newest in a series of anti-vaccine propaganda films produced or promoted by Kennedy was distributed through Ke
    5 KB (630 words) - 15:35, 21 February 2024
  • {{r|Vaccine}}
    724 bytes (94 words) - 17:11, 11 January 2010
  • {{r|Vaccine}}
    830 bytes (105 words) - 01:49, 30 December 2010
  • {{r|Pneumococcal vaccine}}
    768 bytes (98 words) - 11:44, 11 January 2010
  • {{r|Vaccine}}
    868 bytes (111 words) - 17:24, 11 January 2010
  • {{r|Vaccine}}
    946 bytes (116 words) - 19:29, 11 January 2010
  • {{r|Vaccine}}
    958 bytes (113 words) - 15:14, 18 January 2010
  • The '''Nazi typhus and other vaccine experiments''' were conducted for the benefit of the German armed forces to
    967 bytes (114 words) - 01:30, 21 January 2011
  • {{r|Vaccine}}
    865 bytes (112 words) - 21:34, 11 January 2010
  • ...udy of the incidence and complication rates of herpes zoster before zoster vaccine introduction |journal=Mayo Clin. Proc. |volume=82 |issue=11 |pages=1341–9 ...htm |author=Centers for Disease Control and Prevention|title=CBER - Zoster Vaccine, Live, (Oka/Merck), Zostavax Questions & Answers |year=2006|accessdate=2007
    7 KB (1,019 words) - 08:48, 17 March 2011
  • ...ctually a treatment, but prevention, the oil-adjuvant Encephalomyocarditis vaccine. This vaccine has been given to elephants, mice and pigs so far.
    7 KB (1,025 words) - 22:35, 7 February 2010
  • {{r|Vaccine}}
    1 KB (143 words) - 10:58, 11 January 2010
  • {{r|Pneumococcal vaccine}}
    1 KB (134 words) - 15:37, 2 March 2010
  • {{r|Vaccine}}
    1 KB (148 words) - 11:13, 11 January 2010
  • {{r|Pneumococcal vaccine}}
    1 KB (161 words) - 10:26, 8 April 2023
  • {{r|Vaccine}}
    1 KB (144 words) - 11:05, 1 August 2010
  • * {{r|Vaccine }}
    1 KB (163 words) - 07:46, 12 February 2009
  • ...d treatment of influenza virus; the Centers for Disease Control recommends vaccine as first-line prophylaxis in long-term care facilities, with prophylactic u | title = Prevention and Control of Vaccine-Preventable Diseases in Long-Term Care
    5 KB (616 words) - 09:16, 25 August 2010
  • ...[[Nazi sterilization experiments|sterilization]], [[Nazi typhus and other vaccine experiments|typhus]], [[Nazi poison experiments|poison]] and [[Nazi incendi
    1 KB (152 words) - 23:43, 31 December 2010
  • ...as a major cause of death among children and infants. After the pertussis vaccine was introduced, reported cases of this infection decreased by more than 99% ...thy, convulsions and hypotensive-hyporesponsive episodes Currently, a new vaccine is being developed which utilizes recombinant DNA technology. [2]
    10 KB (1,519 words) - 21:39, 1 September 2010
  • {{r|Vaccine}}
    2 KB (208 words) - 04:36, 24 February 2010
  • {{r|Pneumococcal vaccine}}
    2 KB (203 words) - 11:57, 11 January 2010
  • Name = Pneumococcal vaccine | In [[medicine]], pneumococcal vaccines are "[[vaccine]]s or candidate vaccines used to prevent infections with [[streptococcus pn
    14 KB (1,841 words) - 14:09, 2 February 2023
  • While a [[yellow fever]] vaccine has long been available, other vaccine development recently has accelerated.<ref name=CIDRAP /> There has been som | title = Protective efficacy for a live attenuated vaccine against Argentine hemorrhagic fever.
    5 KB (733 words) - 18:58, 26 September 2010
  • {{main|Pneumococcal vaccine}} ...ildren (under 60 months) are given a [[heptavalent pneumococcal conjugate vaccine]] (PCV 7) such as [[Prevnar]].
    9 KB (1,183 words) - 07:31, 15 September 2013
  • {{r|Vaccine}}
    2 KB (241 words) - 04:35, 24 February 2010
  • {{r|Nazi typhus and other vaccine experiments}}
    2 KB (251 words) - 12:04, 18 May 2023
  • ...erpes zoster]] and measles vaccines and the bacillus Calmette-Guérin (BCG) vaccine. An example of inactivated vaccines is the polio vaccine.
    7 KB (1,004 words) - 10:12, 30 May 2009
  • ...at high risk. There have been manufacturing and efficacy problems with the vaccine.
    2 KB (249 words) - 10:42, 8 April 2024
  • .... They are the WC/rBS vaccine, Variant WC/rBS vaccine, and the CVD 103-HgR vaccine. ...Vietnam exclusively. The third oral vaccine for cholera is the CVD 103-HgR vaccine which contains an attenuated live strain of ''Vibrio cholerae'' strain O1 w
    12 KB (1,828 words) - 17:19, 27 February 2012
  • ...(Rv1737c) and narX (Rv1736c), may be used to differentiate between the BCG vaccine, and latent tuberculosis. <ref>http://www.ncbi.nlm.nih.gov/pubmed/18362135?
    8 KB (1,214 words) - 15:31, 30 October 2013
  • {{r|Pneumococcal vaccine}}
    2 KB (310 words) - 12:22, 18 April 2024
  • ...r than most [[primary prevention]] efforts in health care such as [[infant vaccine]]s, [[mammography]] and [[Papanicolaou smear]]s.<ref name="pmid9691106">{{c
    2 KB (286 words) - 11:54, 2 February 2023
  • * Bonah, Christian. "The 'Experimental Stable' of the BCG Vaccine: Safety, Efficacy, Proof, and Standards, 1921-1933." ''Studies in History a
    2 KB (256 words) - 03:39, 19 September 2013
  • | vaccine/antigen | [[vaccine]], [[antigen]]
    6 KB (792 words) - 21:21, 12 December 2008
  • ==The Varicella Zoster Vaccine== ...la Vaccine is another way to get vaccinated, but it contains 10 times more vaccine than Varivax.
    19 KB (2,917 words) - 10:07, 14 May 2012
  • ...in each individual so it is hard to obtain the right information on how a vaccine should be developed. ...for HSV-1 and seronegative for HSV-2. No reasoning was stated in why the vaccine was ineffective on males, regardless if they have shown signs of HSV or not
    18 KB (2,975 words) - 07:13, 28 September 2013
  • ...s?id=Wv1lAAAAEBAJ Common Cold Antigen]. Google Patents.</ref> The proposed vaccine was oral and its target was pneumococcal antigens.
    6 KB (862 words) - 11:49, 2 February 2023
  • ...human cadavers. In 1986 the FDA approved the first genetically engineered vaccine for humans, for hepatitis B.<ref name="timeline"/> Since these early uses o ...[[biotechnology|biotechnological]] applications of GM, for example oral [[vaccine]]s produced naturally in fruit, at very low cost.
    7 KB (1,045 words) - 06:31, 9 June 2009
  • ...ned by the bacterium. Current research is focusing on the development of a vaccine to create immunity against the bacteria and many in the medical community a ...t has not been eliminated) has highlighted the importance of researching a vaccine to help relieve infection. <ref name=epi/>.
    23 KB (3,336 words) - 11:50, 22 December 2015
  • ===Vaccine development=== ...so play a role in prevention. Recent studies have shed light on a possible vaccine developed through mucosal administration of purified recombinant sub-unit p
    12 KB (1,766 words) - 01:02, 2 November 2013
  • ...named it HPV-18. His groundbreaking discovery led to the development of a vaccine and he was recognized with the 2008 Nobel Prize for physiology or medicine. ...ties. The study concludes that more research will need to be done when the vaccine is actually administered at which point similar tests should be done to det
    16 KB (2,356 words) - 13:19, 2 February 2023
  • **Laboratory for Vaccine-Preventable Diseases
    3 KB (461 words) - 08:31, 11 September 2023
  • ...ww.cdc.gov/ncidod/dbmd/diseaseinfo/typhoidfever_t.htm}}</ref> There is a [[vaccine]], but recommended only for travelers to endemic areas.<ref name=MMWR>{{cit
    3 KB (424 words) - 14:34, 2 February 2023
  • ...most recent application of ''Lactococcus lactis'' is in the development of vaccine delivery systems. ''L. lactis'' can be genetically engineered to generate ...is outcome has encouraged the further development of a L. lactis based HIV vaccine.<ref>[http://www.ncbi.nlm.nih.gov/pubmed/12649143 Xin KQ., Hoshino, Y., Tod
    11 KB (1,702 words) - 20:47, 8 November 2013
  • ...TP-Polio-Hib (diphtheria/tetanus/pertussis/polio/haemophilus influenzae b) vaccine, are given at the ages of two, three, and four months, followed by a [[Boos
    3 KB (473 words) - 02:15, 15 November 2007
  • {{r|Vaccine}}
    4 KB (486 words) - 19:46, 11 January 2010
  • ...rom affecting a treated animal, yet distemper is still prevalent since the vaccine is not accessible to all animals that are susceptible to the virus.<ref>[ht
    8 KB (1,179 words) - 16:32, 7 November 2013
  • ...wever, this vaccine is not commercially available in the United States. A vaccine for use in animals has also been developed, but it is not available in the
    9 KB (1,339 words) - 12:54, 4 April 2009
  • ...oyola.edu/~klc/BL472/Malaria/research.html Erin McNamara, Current drug and vaccine research on malaria]</ref>
    12 KB (1,931 words) - 23:28, 26 October 2013
  • ...ces a Protective Immune Response in Mice with Lyme Disease. ''Clinical and Vaccine Immunology, 15''. (9), 1429-1435</ref>
    10 KB (1,451 words) - 04:06, 16 February 2010
  • ...accine.2008.02.015 "Oral administration of a Bacillus subtilis spore-based vaccine expressing Clonorchis sinensis tegumental protein 22.3 kDa confers protecti ...C. sinensis. ''B. subtilis'' spores, thus, are a promising potential oral vaccine vehicle for the prevention and control of clonorchiasis and other gastroint
    16 KB (2,248 words) - 05:12, 30 October 2013
  • ...cal warfare research center. Not all personnel there were protected by the vaccine, and it is not recommended for post-exposure prophylaxis, but only for labo
    10 KB (1,405 words) - 04:47, 26 October 2013
  • ...vive for long periods of time. These genes are important when developing a vaccine for CMV. Currently, there is no vaccine for CMV, but preventative measures can be taken to keep from getting the vi
    21 KB (3,267 words) - 20:07, 1 November 2013
  • ...f Meta-Analysis: Nicotine Gum and Smoking Cessation and the Effcacy of BCG Vaccine in the Treatment of Tuberculosis]" in "A Handbook of Statistical Analyses U
    5 KB (671 words) - 11:50, 1 July 2012
  • A large outbreak was secondary to the 1976 swine influenza vaccine.
    4 KB (489 words) - 16:48, 19 August 2010
  • ...ine from a licenced veterinarian, followed by 2 more shots of the modified vaccine until the puppy is around the age of 16 weeks. It is recommended that dogs
    7 KB (1,155 words) - 00:59, 12 February 2010
  • ...the [[United Kingdom]] regarding a potential link between the combined MMR vaccine (vaccinating children from mumps, measles and rubella) and autism prompted
    8 KB (1,223 words) - 13:22, 2 February 2023
  • ...chicken eggs and produced a vaccine from an attenuated virus strain; this vaccine saved millions of lives and is still being used today. ...[[Jonas Salk]] in deriving a polio vaccine from killed polio viruses; this vaccine was shown to be effective in 1955.
    16 KB (2,389 words) - 01:43, 30 December 2010
  • ...kunks'''<ref>Jojola, S.M., Robinson, S.J., & VerCauteren, K.C. Oral rabies vaccine (ORV) bait uptake by captive striped skunks. Journal of Wildlife Diseases 2 ...pressurized VC to increase the possibility of VC puncture and ingestion of vaccine by the skunks.
    20 KB (2,992 words) - 20:47, 9 June 2010
  • * [http://www.iom.edu/CMS/3793/21144/25184.aspx Vaccine Safety Research, Data Access, and Public Trust: 02-17-2005]
    6 KB (894 words) - 07:53, 31 May 2009
  • ...op, but is the only one of the three serogroups that there has yet to be a vaccine developed for. ...haride vaccines, current researchers have set out to develop and effective vaccine for serogoup B using outer membrane protein- and lipopolysaccharide- based
    14 KB (2,090 words) - 09:50, 19 September 2013
  • As a result of the currently available vaccine, the number of acute hepatitis B infections in the United States has been s ...nflammatory demyelination in childhood<ref>Mikaeloff, Y (2009) Hepatitis B vaccine and the risk of CNS inflammatory demyelination in childhood. ''NEUROLOGY''
    24 KB (3,686 words) - 21:08, 2 February 2012
  • ...reactivity testing were performed. Their results showed that Lyme disease vaccine is not a major factor in the development of arthritis.<ref name=art3>{{Cite
    20 KB (2,900 words) - 03:34, 16 February 2010
  • ...ns used in vaccine effectiveness studies--and its impact on meta-analysis. Vaccine. 2006 Nov 10;24(44-46):6602-4. Epub 2006 Jun 8. ...asurel N, Sprenger MJ, Knottnerus JA| title=Adverse reactions to influenza vaccine in elderly people: randomised double blind placebo controlled trial. | jour
    37 KB (5,103 words) - 13:22, 2 February 2023
  • ...rom affecting a treated animal, yet distemper is still prevalent since the vaccine is not accessible to all animals that are susceptible to the virus. The vir
    12 KB (1,796 words) - 00:00, 21 October 2013
  • ...S. (2008, September 23). An outer membrane protein, OmpK, is an effective vaccine candidate for Vibrio harveyi in Orange-spotted grouper (Epinephelus coioide
    13 KB (2,004 words) - 04:09, 16 February 2010
  • ...Greenfield, worked on anthrax, and succeeded in producing an attenuated [[vaccine]] before [[Pasteur]], a feat not widely acknowledged either now or at the t
    6 KB (911 words) - 17:49, 8 January 2008
  • ...se]]s and respond to [[pathogen]]s, [[chemical]]s, [[medication|drugs]], [[vaccine]]s, and other agents. SNPs are also thought to be key enablers in realizin
    7 KB (957 words) - 10:47, 30 March 2010
  • # Vaccine
    10 KB (1,416 words) - 02:25, 13 October 2019
  • ...re are worldwide preparations for containing and treating an outbreak. The vaccine, while having significant side effects, can reduce the severity of an activ ...after 2001 America currently has roughly one hundred million doses of the vaccine and has purchased a contract that would ensure enough doses for the America
    19 KB (3,021 words) - 01:43, 6 February 2010
  • {{Image|Pfizer vaccine friend.jpg|left|350px|Example of a vaccine card, personal details obscured here for privacy.}} ...nal travellers to countries requiring proof of vaccination against certain vaccine preventable diseases, such as yellow fever and, more recently in selected r
    53 KB (8,307 words) - 09:59, 9 March 2024
  • ***Malaria Vaccine Initiative at the [[Program for Appropriate Technologies in Health]] (PATH) While there is no vaccine, chemoprophylaxis can be effective, although, as with the use of anti-malar
    15 KB (2,133 words) - 02:31, 27 October 2010
  • ...ure environment. The freezing of foods and biotechnology products, like [[vaccine]]s, requires nitrogen in blast freezing or immersion freezing systems. Cert
    7 KB (1,043 words) - 09:37, 6 March 2024
  • ...as used to reduce symptomatic infections, which are rare, by 80-90%. This vaccine requires three 1.0 ml subcutaneous injections on specific days, for infants
    17 KB (2,632 words) - 01:36, 22 April 2014
View (previous 100 | ) (20 | 50 | 100 | 250 | 500)